{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:07:39Z","timestamp":1790986059537,"version":"4.1.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"9272","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1016\/s0140-6736(00)05083-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T18:15:33Z","timestamp":1027620933000},"page":"1946-1947","source":"Crossref","is-referenced-by-count":71,"title":["Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib"],"prefix":"10.1016","volume":"357","author":[{"given":"Jose L","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Fern\u00e1ndez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(00)05083-2_bib1","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1016\/S0002-9343(99)00369-1","article-title":"Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2-selective inhibition","volume":"107","author":"Brater","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/S0140-6736(00)05083-2_bib2","first-page":"25","article-title":"Significant upper gastrointestinal events associated with conventional NSAID versus celecoxib","volume":"60","author":"Goldstein","year":"2000","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/S0140-6736(00)05083-2_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0272-6386(00)70266-6","article-title":"Are selective COX-2 inhibitors nephrotoxic?","volume":"35","author":"Perazella","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(00)05083-2_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1523-1755.1998.00001.x","article-title":"The clinical spectrum of tubulointerstitial nephritis","volume":"54","author":"Rastegar","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/S0140-6736(00)05083-2_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2125.2000.00229.x","article-title":"The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19087 patients in general practice in England: cohort study","volume":"50","author":"Martin","year":"2000","journal-title":"Br J Clin Pharmacol"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673600050832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673600050832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T01:23:01Z","timestamp":1556068981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673600050832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":5,"journal-issue":{"issue":"9272","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S0140673600050832"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(00)05083-2","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}